Measles-free status of Canada revoked
On 10 November 2025, the revocation of Canada's measles elimination status was announced by the Pan American Health Organization (PAHO).…
All articles by GlobalData Healthcare
GlobalData Healthcare
-
-
Obstructive sleep apnea independently associated with cerebral microbleeds
Obstructive sleep apnea (OSA) is a condition in which airflow is blocked during sleep for longer than 10 seconds at…
-
AHA 2025: SHR-1918’s impact on hyperlipidaemia through angiopoietin-like 3 inhibition
On 10 October, at the American Heart Association (AHA) 2025 conference in New Orleans, Louisiana, US, during a late-breaking session…
-
Physical activity effects mortality risk in epilepsy
Exercise has traditionally been associated with better health outcomes. According to the World Health Organization, there are various physical and…
-
AHA 2025: sotatercept shows survival edge in pulmonary arterial hypertension
At the 2025 American Heart Association (AHA) Scientific Sessions in New Orleans, researchers shared pooled results from three major clinical…
-
AHA 2025: satralizumab shows benefit in immune-driven pulmonary arterial hypertension
At the 2025 American Heart Association (AHA) Scientific Sessions in New Orleans, investigators from Japan presented results from the SATISFY-JP…
-
Sotagliflozin demonstrates structural and functional benefits in nondiabetic HFpEF
On 8 November at this year’s American Heart Association conference, during a clinical session on the topic of 'Heart Failure…
-
Study explores chronic health outcomes associated with polycystic ovary syndrome
The hormonal and metabolic disturbances associated with polycystic ovary syndrome (PCOS) are a risk factor for a variety of health…
-
ESMO 2025: AstraZeneca and Daiichi Sankyo establish Enhertu in early breast cancer
18 October marked the presentation of the highly anticipated DESTINY-Breast05 and DESTINY-Breast11 trials at the 2025 European Society for Medical…
-
ESMO 2025: Celcuity gets first positive results for Pi3K inhibitor in PiK3CA wild-type HR+/HER2 breast cancer
At the European Society for Medical Oncology (ESMO) 2025 event, held in Berlin, Germany, between 17-21 October, Celcuity presented results…